An Open Label Trial Evaluating the Efficacy of Lacticaseibacillus Paracasei PS23 on Cognition

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 10, 2025

Primary Completion Date

August 18, 2026

Study Completion Date

December 31, 2026

Conditions

Subjective Cognitive Decline (SCD)

Interventions

DIETARY_SUPPLEMENT

Lacticaseibacillus paracasei

one capsule daily for 12 weeks

All Listed Sponsors

collaborator

Bened Biomedical Co., Ltd.

INDUSTRY

lead

Chi-Chang Huang

OTHER

NCT07168824 - An Open Label Trial Evaluating the Efficacy of Lacticaseibacillus Paracasei PS23 on Cognition | Biotech Hunter | Biotech Hunter